Increased cerebrospinal fluid production as a possible mechanism underlying caffeine's protective effect against Alzheimer's disease

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Wostyn, Peter ^a   Van Dam, Debby ^b   Audenaert, Kurt ^c   De Deyn, Peter Paul ^b,d  

^a PC Sint Amandus ^*  (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d MIDDELHEIM HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMYLOID BETA PROTEIN; CAFFEINE;

ALZHEIMER DISEASE; BRAIN BLOOD FLOW; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID FLOW; CHOROID PLEXUS; COFFEE; DIETARY INTAKE; DRUG EFFECT; DRUG MECHANISM; HUMAN; LOW DRUG DOSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

EID: 80052683178     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/617420     Document Type: Review

References (32)

1. Wostyn P., Audenaert K., De Deyn P. P., Alzheimer's disease-related changes in diseases characterized by elevation of intracranial or intraocular pressure Clinical Neurology and Neurosurgery 2008 110 2 101 109
2. Wostyn P., Audenaert K., De Deyn P. P., Alzheimer's disease and glaucoma: Is there a causal relationship? British Journal of Ophthalmology 2009 93 12 1557 1559
3. Sleegers K., Lambert J. C., Bertram L., Cruts M., Amouyel P., Van Broeckhoven C., The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects Trends in Genetics 2010 26 2 84 93
4. Chen X., Ghribi O., Geiger J. D., Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases Journal of Alzheimer's Disease 2010 20 supplement 1 127 141
5. Arendash G. W., Schleif W., Rezai-Zadeh K., Jackson E. K., Zacharia L. C., Cracchiolo J. R., Shippy D., Tan J., Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain -amyloid production Neuroscience 2006 142 4 941 952 (Pubitemid 44740473)
6. Maia L., de Mendona A., Does caffeine intake protect from Alzheimer's disease? European Journal of Neurology 2002 9 4 377 382 (Pubitemid 35013893)
7. Lindsay J., Laurin D., Verreault R., Hébert R., Helliwell B., Hill G. B., McDowell I., Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging American Journal of Epidemiology 2002 156 5 445 453 (Pubitemid 34976983)
8. Silverberg G. D., Mayo M., Saul T., Rubenstein E., McGuire D., Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis Lancet Neurology 2003 2 8 506 511 (Pubitemid 36876108)
9. Silverberg G. D., Heit G., Huhn S., Jaffe R. A., Chang S. D., Bronte-Stewart H., Rubenstein E., Possin K., Saul T. A., The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer's type Neurology 2001 57 10 1763 1766 (Pubitemid 33096680)
10. Ott B. R., Cohen R. A., Gongvatana A., Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease Journal of Alzheimer's Disease 2010 20 2 647 657
11. Serot J. M., Bene M. C., Faure G. C., Normal-pressure hydrocephalus and Alzheimer disease Journal of Neurosurgery 2003 99 4 797 798
12. Brown P. D., Davies S. L., Speake T., Millar I. D., Molecular mechanisms of cerebrospinal fluid production Neuroscience 2004 129 4 957 970 (Pubitemid 39556247)
13. Serot J. M., Béné M. C., Foliguet B., Faure G. C., Morphological alterations of the choroid plexus in late-onset Alzheimer's disease Acta Neuropathologica 2000 99 2 105 108 (Pubitemid 30093415)
14. Serot J. M., Béné M. C., Faure G. C., Choroid plexus, ageing of the brain, and Alzheimer's disease Frontiers in Bioscience 2003 8 s515 s521
15. Han M. E., Kim H. J., Lee Y. S., Regulation of cerebrospinal fluid production by caffeine consumption BMC Neuroscience 2009 10, article 110 12
16. Richards K. S., Bommert K., Szabo G., Miles R., Differential expression of Na/K-ATPase -subunits in mouse hippocampal interneurones and pyramidal cells Journal of Physiology 2007 585 2 491 505 (Pubitemid 350193920)
17. Masseguin C., LePanse S., Corman B., Verbavatz J. M., Gabrion J., Aging affects choroidal proteins involved in CSF production in Sprague-Dawley rats Neurobiology of Aging 2005 26 6 917 927 (Pubitemid 40249495)
18. Fredholm B. B., Bttig K., Holmén J., Nehlig A., Zvartau E. E., Actions of caffeine in the brain with special reference to factors that contribute to its widespread use Pharmacological Reviews 1999 51 1 83 133 (Pubitemid 29113867)
19. Rahman A., The role of adenosine in Alzheimer's disease Current Neuropharmacology 2009 7 3 207 216
20. Eskelinen M. H., Ngandu T., Tuomilehto J., Soininen H., Kivipelto M., Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study Journal of Alzheimer's Disease 2009 16 1 85 91
21. Lammi U. K., Kivel S. L., Nissinen A., Punsar S., Puska P., Karvonen M., Mental disability among elderly men in Finland: prevalence, predictors and correlates Acta Psychiatrica Scandinavica 1989 80 5 459 468 (Pubitemid 19282118)
22. van Gelder B. M., Buijsse B., Tijhuis M., Coffee consumption is inversely associated with cognitive decline in elderly European men: the FINE Study European Journal of Clinical Nutrition 2007 61 2 226 232
23. Ritchie K., Carrire I., de Mendona A., Portet F., Dartigues J. F., Rouaud O., Barberger-Gateau P., Ancelin M. L., The neuroprotective effects of caffeine: a prospective population study (the Three City Study) Neurology 2007 69 6 536 545 (Pubitemid 47357260)
24. Santos C., Lunet N., Azevedo A., de Mendona A., Ritchie K., Barros H., Caffeine intake is associated with a lower risk of cognitive decline: a cohort study from Portugal Journal of Alzheimer's Disease 2010 20 supplement 1 175 185
25. Santos C., Costa J., Santos J., Vaz-Carneiro A., Lunet N., Caffeine intake and dementia: systematic review and meta-analysis Journal of Alzheimer's Disease 2010 20 supplement 1 187 204
26. Biessels G. J., Caffeine, diabetes, cognition, and dementia Journal of Alzheimer's Disease 2010 20 supplement 1 143 150
27. Cao C., Cirrito J. R., Lin X., Wang L., Verges D. K., Dickson A., Mamcarz M., Zhang C., Mori T., Arendash G. W., Holtzman D. M., Potter H., Caffeine suppresses amyloid- levels in plasma and brain of Alzheimer's disease transgenic mice Journal of Alzheimer's Disease 2009 17 3 681 697
28. Arendash G. W., Mori T., Cao C., Mamcarz M., Runfeldt M., Dickson A., Rezai-Zadeh K., Tan J., Citron B. A., Lin X., Echeverria V., Potter H., Caffeine reverses cognitive impairment and decreases brain amyloid- levels in aged Alzheimer's disease mice Journal of Alzheimer's Disease 2009 17 3 661 680
29. Van Dam D., De Deyn P. P., Drug discovery in dementia: the role of rodent models Nature Reviews Drug Discovery 2006 5 11 956 970 (Pubitemid 44660608)
30. Pappenheimer J. R., Heisey S. R., Jordan E. F., Downer J. C., Perfusion of the cerebral ventricular system in unanesthetized goats American Journal of Physiology 1962 203 763 774
31. Chodobski A., Szmydynger-Chodobska J., Johanson C. E., Vasopressin mediates the inhibitory effect of central angiotensin II on cerebrospinal fluid formation European Journal of Pharmacology 1998 347 2-3 205 209 (Pubitemid 28234458)
32. Oshio K., Watanabe H., Song Y., Verkman A. S., Manley G. T., Reduced cerebrospinal fluid production and intracranial pressure in mice lacking choroid plexus water channel Aquaporin-1 FASEB Journal 2005 19 1 76 78 (Pubitemid 40069923)